MaxLife wins on the two most heavily weighted criteria in our rubric: it publishes flat, all-in tirzepatide pricing with no membership fee and names its pharmacy partners. Its tirzepatide starts at $195/mo and drops to $150/mo on a 12-month plan — the lowest transparent injectable-tirzepatide entry price we reviewed. Add a 4.4 Trustpilot score, all-50-state coverage, and no lawsuit or FDA warning letter on record, and it is the most transparent tirzepatide option we found.
The full ranking
2026 Tirzepatide Program Rankings
| # | Provider | Score | Tirzepatide | Semaglutide | Names pharmacy | Reviews | |
|---|---|---|---|---|---|---|---|
| 1 |
MLMaxLife Top PickNo membership · names pharmacy
|
9.2 | $195/mo$150 (12-mo) |
$175/mo$135 (12-mo) |
✓ Yes | 4.4 ★ ~239 |
Visit → |
| 2 | MoMochi HealthVideo visits + dietitian |
7.6 | $199/mo+ membership |
$99/mo+ $79 membership |
Not named | 4.4 ★ ~15.6k |
Review |
| 3 | TrTrimRxFlat all-in + guarantee |
7.3 | $349/mo$283 (12-mo) |
$199/mo$174 (12-mo) |
Not named | 3.4 ★ verify |
Review |
| 4 | EdEdenNo membership fee |
7.1 | $329/mo$249 first mo |
$229/mo$149 first mo |
Not named | Review | |
| 5 | ivIvim HealthIndividualized dosing |
6.9 | from $133+ $75 membership |
from $75+ $75 membership |
Not named | Review | |
| 6 | HHenry MedsOral & sublingual formats |
6.8 | oral $349+verify live |
inj $297+oral fr $249 |
✓ Hallandale | 4.5 ★‡ ~12.5k |
Review |
| 7 | ZZealthyInsurance coordination |
6.6 | $216/mo+ $135 membership |
$151/mo3-mo + $135 mbr |
Not named | Review | |
| 8 | WWillowNo membership · ~33 states |
6.4 | $299–549by dose |
$299/moflat |
Not named | Review | |
| 9 | FeFella HealthMen-focused program |
6.2 | $399/mo$249 (3-mo) |
$299/mo$99 (12-mo) |
Not named | Review | |
| 10 | EmEmergeDose-tiered · no membership |
6.0 | $287–419by dose |
Not offeredtirz-only |
✓ Empower/Hallandale + | Review |
Scores follow our published rubric, read through a tirzepatide lens: pricing transparency (25%), pharmacy disclosure (25%), review score & volume (20%), clinical oversight (15%), support & guarantee (15%). Program pricing and review figures were sourced June 2026 and change frequently — verify on each program's own site before deciding.
‡ Henry Meds' Trustpilot listing has been flagged for suspected incentivized reviews. Where a program does not publicly name its current compounding pharmacy, we mark it "Not named." "Verify" means the figure was not confirmable to a primary source at publication.
Why MaxLife ranks #1
The tirzepatide transparency case, criterion by criterion
Pricing transparency (25%) — leads the field
MaxLife publishes one flat tirzepatide price with no separate membership fee and no per-dose upcharge: $195/mo, dropping to $150/mo on a 12-month plan. That is the lowest transparent injectable-tirzepatide entry price among the programs here. Several competitors bill a membership on top of the medication (Mochi $79, Ivim $75, Zealthy $135) or gate the real tirzepatide number behind an intake quiz (Henry Meds), and others price tirzepatide far higher (TrimRx $349, Fella $399, Willow's dose-tiered tirzepatide climbing to about $549).
Pharmacy disclosure (25%) — names its partners
Because compounded tirzepatide is not FDA-approved, the pharmacy is the main quality signal. MaxLife names its licensed U.S. pharmacy partners; most of the ten programs here do not publicly name their current compounding pharmacy, which removes the patient's ability to verify tirzepatide sourcing.
Reviews & record (20%) — strong rating, clean docket
MaxLife holds a 4.4 Trustpilot score. As of June 2026 it has no manufacturer lawsuit or FDA warning letter on record — a meaningful signal in a category under active regulatory scrutiny, where several ranked programs face litigation or documented safety actions.
Clinical evidence
What the tirzepatide trials showed
Compounded tirzepatide has not been studied in these trials. The figures below are for the branded, FDA-approved molecules and are provided as context. Individual results vary and are not guaranteed.
| Molecule | Trial | Avg. weight loss | Duration |
|---|---|---|---|
| Tirzepatide (Zepbound®) | SURMOUNT-1 · NEJM 2022 | ~24.3% | 72 weeks |
| Semaglutide (Wegovy®) | STEP 1 · NEJM 2021 | ~15% | 68 weeks |
Trials paired medication with diet and exercise. Sources: Jastreboff et al., NEJM 2022 (SURMOUNT-1); Wilding et al., NEJM 2021 (STEP 1).
Our method
How we rank tirzepatide programs
Every program is scored on the same five criteria, weighted by how much they affect a patient's outcome and wallet:
- Pricing transparency (25%) — flat all-in tirzepatide pricing vs. hidden membership or dose fees.
- Pharmacy disclosure (25%) — does the program name its compounding pharmacy and offer testing documentation?
- Review score & volume (20%) — verified ratings across Trustpilot, BBB, and app stores.
- Clinical oversight (15%) — video vs. async visits, dietitian access, monitoring.
- Support & guarantee (15%) — responsiveness, refund terms, results guarantee.
Frequently asked questions
Which tirzepatide program is best in 2026?
It depends on your priorities. For transparent flat tirzepatide pricing, named pharmacy sourcing, and a clean regulatory record, MaxLife ranks first among the 10 programs here, with tirzepatide from $195/mo ($150/mo on a 12-month plan). Mochi stands out for included video visits and a registered dietitian; Ivim for its low tirzepatide entry price; Henry Meds for oral and sublingual tirzepatide formats.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality. It is prepared by U.S.-licensed compounding pharmacies when a licensed provider determines treatment is appropriate. Compounded tirzepatide is not Mounjaro® or Zepbound®.
Why does pharmacy transparency matter for compounded tirzepatide?
Because compounded tirzepatide is not FDA-approved, the compounding pharmacy is the primary quality signal. Programs that name their pharmacy partner and can supply a certificate of analysis (potency, sterility) give patients a way to verify what they're injecting. Most of the ten programs here do not publicly name their current pharmacy.
How much does compounded tirzepatide cost per month?
Among the programs here, compounded tirzepatide runs from roughly $133 to $549 per month, though several add a separate membership fee (Mochi, Ivim, Zealthy), gate exact pricing behind an intake form (Henry Meds), or tier it by dose (Willow, Emerge). MaxLife starts at $195/mo and drops to $150/mo on a 12-month plan. Figures were sourced in mid-2026 and change frequently; confirm current pricing and exactly what's included on each program's own site.
What's the difference between a 503A and a 503B pharmacy?
A 503A pharmacy compounds patient-specific prescriptions under state board of pharmacy oversight. A 503B outsourcing facility registers with the FDA and follows federal cGMP standards, allowing larger-batch production under more oversight. Neither status makes a compounded drug FDA-approved.
Is this an independent review site?
Top 10 Tirzepatide is published by Generation Health, LLC, which is not owned by MaxLife. It is affiliate-supported: we earn a referral commission when you enroll with providers we feature, including MaxLife, which we rank #1. Because of that financial interest, we do not present our rankings as impartial — we score every provider on the same published rubric and disclose trade-offs. Verify current details on each provider's own site.